Published on November 11, 2009 at 3:21 AM
Reportlinker.com announces that a new market research report is available in its catalogue.
Injectable Drug Delivery: Market Impact and Industry Trends
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances.
The global market for drug delivery technology is worth in excess of US$25 billion in sales. Given its predicted annual growth of 15 percent, the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. According to The author; new report entitled Injectable Drug Delivery: Market Impact and Industry Trends, injectables currently account for an estimated 15 percent of the global drug delivery market, with the US being the leading individual market.
Key features of this report:
- Overview of the drug delivery environment
- In-depth analysis of the injectable drug delivery industry, including main types and main marketed systems, and their advantages and disadvantages
- Comprehensive facts and figures for the injectable drug delivery market, including main players and key therapeutic areas
- Future trends in the injectables marketplace, shaped by medical and technological advances as much as demographic and epidemiological changes and industry needs
- Outlook for the injectable drug delivery technology
Who should buy this report?
- Stakeholders in the injectable drug delivery market
- Companies interested in understanding the impact and implications of securing the correct injectable drug delivery technology in terms of product placement, lifecycle management and competition in the marketplace
- Companies interested in understanding future opportunities in the injectable drug delivery sector provided by a combination of factors, including changing public health needs
- Pharma/biotech companies wishing to identify potential injectable drug delivery areas for partnerships and collaboration in order to examine a variety of profit maximization strategies
SOURCE Reportlinker
bb603ef9-6d36-47c9-b88c-02946d45ee51|0|.0
Posted in: Device / Technology News
Tags: Acromegaly, Arthritis, Crohn's Disease, Diabetes, Drug Delivery, Hepatitis C, Macular Degeneration, Morphine, Multiple Sclerosis, Nanocrystal, Neutropenia, Oncology, Paliperidone Palmitate, Photodynamic Therapy, Psoriasis, Rheumatoid Arthritis, Rheumatology, Vivitrol